Jump to content

BioMérieux

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by AnomieBOT (talk | contribs) at 05:05, 5 April 2016 (Dating maintenance tags: {{Refimprove}}). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

bioMérieux
Company typeSociété Anonyme
EuronextBIM
Founded1963; 61 years ago (1963)
FounderTemplate:Dr-make parameter {{{2}}} must be y, d, c, or m Alain Mérieux
HeadquartersMarcy-l'Étoile, France
Area served
Worldwide
Key people
Jean-Luc Bélingard
(CEO)
Alexandre Mérieux
(Chairman)
Template:Dr-make parameter {{{2}}} must be y, d, c, or m Marcel Mérieux, Template:Dr-make parameter {{{2}}} must be y, d, c, or m Charles Mérieux
Revenue1,698 M€ (2014) [1] Increase +7 % vs 2013
587,000,000 Euro (2022) Edit this on Wikidata
452,000,000 Euro (2022) Edit this on Wikidata
Number of employees
8 935
Websitewww.biomerieux.com

bioMérieux (EuronextBIM) is a multinational biotechnology company founded and headquartered in France. A world leader in the field of in vitro diagnostics for 50 years, bioMérieux is present in more than 150 countries through 42 subsidiaries and a large network of distributors.

bioMérieux provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the NYSE Euronext Paris stock exchange (BIM – ISIN: FR0010096479).

Revenue

bioMérieux has revenues of €1.698 billion as of 2014 with 88% of sales occurring outside France.

History

  • Alain Mérieux founded the company in 1963.
  • Institut Mérieux, which belongs to the Mérieux family, is the main shareholder of bioMérieux.
  • Jean-Luc Belingard is President [2]
  • Alexandre Mérieux is General Director[3]

References